Medtech in a Minute: Dexcom, Medtronic, and Baxter

Video transcript:

Voice Over: Dexcom Brings CGM to the Masses. FDA cleared the first glucose biosensor available without a prescription.

Medtronic Goes After Axonics Again. Medtronic says Axonics is illegally using its MRI compatibility tech. Axonics says Medtronic is trying to stifle competition. Meanwhile, Boston Scientific is in the process of buying Axonics.

Baxter Backpedals on Kidney Spinoff. Baxter may sell its kidney care business to private equity investors instead of its previous spin-off plans announced last year.